Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study

Chronic anticoagulation is recommended for atrial fibrillation (AF) patients with thromboembolic risk factors regardless of AF duration/frequency. Continuous rhythm assessment with pacemakers (PMs)/implantable cardioverter-defibrillators (ICDs) and use of direct-acting oral anticoagulants (DOACs) may allow anticoagulation only around AF episodes, reducing bleeding without increasing thromboembolic risk.

Source: Heart Rhythm - July 5, 2018 Category: Cardiology Authors: Jonathan W. Waks, Rod S. Passman, Jason Matos, Matthew Reynolds, Amit Thosani, Theofanie Mela, David Pederson, Taya V. Glotzer, Peter Zimetbaum Source Type: research